Research Manipulation

Question: Are these misleading statistics or research fraud? Answer: As per the observation of the given video, the major concern is Dr. Anil Potti, who was claimed to manipulate data of clinical cancer research for establishing his cancer research strategy. It is a research fraud. It has been found that his strategy failed with the original data but got successful results with manipulated data (Fuerst, 2012). This incidence was about a clinical trial in which a patient, Julia Jacobs died after three months of the clinical trial. These kinds of research frauds are more common than limits of human perception. In this context, research laboratories should introduce more advanced review team through the provision of adequate training. The level of retractions is enhancing and these fraudsters are setting new records like Dr. Potti, who is working in South Carolina as a cancer doctor and his online profile is showing his significant contribution in lung cancer research (Fuerst, 2012). To reduce these kinds of fraud cases, more efficient institutional review board should be established. If someone is shown to do this kind of research fraud, the consequences should lead to his compensation for this. The research license should be banned. The training and mentoring programs should be established with improved quality. These cases shown in the video are categorized as research fraud, not misleadin g statistics, as the data were being manipulated for establishing the research strategy (Fang, Steen Casadevall, 2012). A policy, acknowledging the crucial contributions of whistleblowers could be introduced for effective protection measures in the laboratories. In addition, another important point is that, immediately after addressing these facts, the paper should be banned for public access (Fang, Steen Casadevall, 2012). Reference List Fang, F. C., Steen, R. G., Casadevall, A. (2012). Misconduct accounts for the majority of retracted scientific publications.Proceedings of the National Academy of Sciences,109(42), 17028-17033. Fuerst, H. (2012). Duke Clinical Trials - 60 Minutes. YouTube. Retrieved 19 March 2016, from https://www.youtube.com/watch?v=W5sZTNPMQRM